OSE Immunotherapeutics SA
EPA:OSE.PA
7.5 (EUR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | 2013 Q3 | 2013 Q2 | 2013 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.869 | 1.358 | 2.255 | 16.047 | 17.331 | 8.975 | 4.569 | 5.849 | 9.973 | 15.979 | 3.848 | 20.608 | 3.833 | 2.849 | 0.344 | 0.039 | 0.003 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0.869 | 1.358 | 2.255 | 16.047 | 17.331 | 8.975 | 4.57 | 5.849 | 9.973 | 15.979 | 3.848 | 20.608 | 3.833 | 2.849 | 0.344 | 0.039 | 0.003 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 9.736 | 14.427 | 13.505 | 16.496 | 16.831 | 17.145 | 13.268 | 9.087 | 13.491 | 11.6 | 9.06 | 10.63 | 9.02 | 9.547 | 2.68 | 5.351 | 1.915 | 1.024 | 1.746 | 0.387 | 0.075 | 0.038 | 0.079 | 0.04 |
| General & Administrative Expenses
| 2.388 | 3.574 | 2.83 | 3.764 | 5.137 | 3.366 | 4.701 | 0 | 1.714 | 2.141 | 1.757 | 1.664 | 3.146 | 0 | 1.897 | 0.876 | 0.727 | 0.591 | 0.532 | 0.131 | 0.047 | 0.024 | 0.043 | 0.022 |
| Selling & Marketing Expenses
| -2.283 | 0.732 | 1.371 | 0.836 | 0.635 | 2.468 | -1.483 | 0 | 1.001 | 0.584 | 0.435 | 0.542 | -0.79 | 0 | 0.274 | 0.405 | 0.514 | 1.343 | 0 | 0.135 | 0.003 | 0.003 | 0 | 0 |
| SG&A
| 2.589 | 4.306 | 4.201 | 4.6 | 5.772 | 5.834 | 3.218 | 3.848 | 2.715 | 2.725 | 2.192 | 2.206 | 2.356 | 2.295 | 2.171 | 1.281 | 1.241 | 1.934 | 0.532 | 0.266 | 0.053 | 0.027 | 0.043 | 0.022 |
| Other Expenses
| 0 | 0 | -0.029 | -0.049 | -0.058 | -0.047 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 12.325 | 18.733 | 17.735 | 21.145 | 22.661 | 23.026 | 16.486 | 12.935 | 16.206 | 14.325 | 9.211 | 10.387 | 9.215 | 10.173 | 5.101 | 22.277 | 2.669 | 2.922 | 2.182 | 0.655 | 0.127 | -0.064 | 0.123 | -0.062 |
| Operating Income
| -13.152 | -19.203 | -17.254 | -6.768 | -7.078 | -14.895 | -11.917 | -7.086 | -6.495 | 1.434 | -5.51 | 10.357 | -5.289 | -7.336 | -4.791 | 4.224 | -2.621 | -2.799 | -2.161 | -0.654 | -0.128 | -0.064 | -0.122 | -0.061 |
| Operating Income Ratio
| -15.135 | -14.141 | -7.651 | -0.422 | -0.408 | -1.66 | -2.608 | -1.211 | -0.651 | 0.09 | -1.432 | 0.503 | -1.38 | -2.575 | -13.927 | 108.308 | -873.667 | -2,799 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -1.463 | 4.812 | -1.032 | 1.6 | 0.015 | 0.4 | -0.121 | -0.122 | 0.241 | 0.297 | 0.133 | -0.273 | -0.11 | -0.006 | 0.05 | 18.109 | -0.01 | -0.143 | -0.017 | -0.001 | 0.001 | 0.001 | -0.001 | -0.001 |
| Income Before Tax
| -14.615 | -14.391 | -18.286 | -5.168 | -7.063 | -14.495 | -12.038 | -7.208 | -6.254 | 1.731 | -5.377 | 10.084 | -5.399 | -7.342 | -4.741 | 22.333 | -2.631 | -2.942 | -2.178 | -0.655 | -0.127 | -0.064 | -0.123 | -0.062 |
| Income Before Tax Ratio
| -16.818 | -10.597 | -8.109 | -0.322 | -0.408 | -1.615 | -2.635 | -1.232 | -0.627 | 0.108 | -1.397 | 0.489 | -1.409 | -2.577 | -13.782 | 572.641 | -877 | -2,942 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -3.472 | -2.532 | -2.505 | -3.189 | -1.701 | -3.007 | 1.402 | -4.094 | -1.088 | 1.217 | 1.99 | 1.207 | 1.236 | 1.002 | 0.901 | 2.173 | 0.011 | 0 | 0.002 | -0.001 | 0.001 | 0.001 | -0.001 | -0.001 |
| Net Income
| -11.143 | -11.86 | -15.781 | -1.979 | -5.362 | -11.488 | -13.441 | -3.114 | -5.166 | 0.514 | -3.387 | 8.877 | -4.163 | -6.34 | -3.84 | 24.506 | -2.642 | -2.942 | -2.18 | -0.655 | -0.127 | -0.064 | -0.123 | -0.062 |
| Net Income Ratio
| -12.823 | -8.733 | -6.998 | -0.123 | -0.309 | -1.28 | -2.942 | -0.532 | -0.518 | 0.032 | -0.88 | 0.431 | -1.086 | -2.225 | -11.163 | 628.359 | -880.667 | -2,942 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.54 | -0.64 | -0.86 | -0.11 | -0.29 | -0.64 | -0.84 | -0.21 | -0.35 | 0.035 | -0.23 | 0.57 | -0.29 | -0.44 | -0.25 | 2.1 | -0.27 | -0.32 | -0.27 | -0.09 | -0.017 | -0.008 | -0.02 | -0.008 |
| EPS Diluted
| -0.54 | -0.64 | -0.86 | -0.11 | -0.29 | -0.64 | -0.84 | -0.21 | -0.35 | 0.032 | -0.22 | 0.57 | -0.29 | -0.44 | -0.25 | 2.1 | -0.26 | -0.32 | -0.27 | -0.086 | -0.017 | -0.008 | -0.016 | -0.008 |
| EBITDA
| -11.456 | -17.375 | -15.48 | -5.098 | -5.33 | -14.051 | -11.762 | -6.954 | -6.233 | 1.654 | -5.454 | 10.417 | -5.25 | -7.252 | -4.707 | 4.247 | -2.532 | -2.789 | -0.017 | -0.001 | 0.001 | -0.128 | -0.001 | -0.123 |
| EBITDA Ratio
| -13.183 | -12.795 | -6.865 | -0.318 | -0.308 | -1.566 | -2.574 | -1.189 | -0.625 | 0.104 | -1.417 | 0.505 | -1.37 | -2.545 | -13.683 | 108.897 | -844 | -2,789 | 0 | 0 | 0 | 0 | 0 | 0 |